SF-36 scale
|
Baseline
|
Follow-up
|
---|
|
AMOS patients (N = 392 patients in 5 cohorts)
|
Corresponding cohorts (N = 552 cohorts)
|
Outcome differences (N = 552 comparisons)
|
---|
|
Mean *
|
SD *
|
Median *
|
N
|
Mean **
|
SD **
|
Median **
|
Mean ***
|
SD ***
|
25-per ***
|
Median ***
|
75-per ***
|
---|
Physical Function
|
72.8
|
23.8
|
80.0
|
62
|
65.1
|
19.2
|
68.6
|
0.6
|
9.4
|
-2.0
|
2.0
|
4.4
|
Role Physical
|
37.4
|
38.5
|
25.0
|
59
|
40.0
|
18.3
|
43.4
|
4.1
|
14.1
|
-6.3
|
5.0
|
12.4
|
Role Emotional
|
42.4
|
41.5
|
33.3
|
59
|
59.2
|
16.6
|
62.2
|
-0.2
|
11.3
|
-7.5
|
-2.0
|
7.7
|
Social Functioning
|
54.8
|
25.1
|
50.0
|
66
|
61.0
|
12.9
|
60.7
|
2.6
|
9.2
|
-2.8
|
2.0
|
8.8
|
Mental Health
|
49.3
|
20.9
|
48.0
|
62
|
61.9
|
10.9
|
64.0
|
2.0
|
6.7
|
-0.9
|
2.2
|
6.4
|
Bodily Pain
|
48.8
|
28.1
|
41.0
|
64
|
45.8
|
15.5
|
44.8
|
2.7
|
10.0
|
-1.7
|
2.8
|
9.2
|
Vitality
|
34.3
|
18.0
|
35.0
|
60
|
45.6
|
9.6
|
47.4
|
3.4
|
6.9
|
-1.0
|
3.9
|
8.7
|
General Health
|
48.3
|
19.9
|
47.0
|
63
|
60.3
|
10.2
|
60.3
|
2.9
|
5.4
|
-1.3
|
4.0
|
6.9
|
Physical Component
|
41.7
|
10.2
|
41.3
|
27
|
37.3
|
7.6
|
37.7
|
1.5
|
3.9
|
-0.3
|
2.4
|
3.9
|
Mental Component
|
35.6
|
12.7
|
34.0
|
30
|
40.4
|
7.7
|
42.4
|
0.3
|
5.0
|
-3.6
|
-0.5
|
3.7
|
- *of patients. **of cohorts. ***of differences. N: Number of cohorts. 25-per: 25-percentile. 75-per: 75-percentile. Each outcome difference refers to one SF-36 scale at the last evaluable follow-up of the corresponding cohort: Mean difference from baseline in AMOS cohort minus mean difference from baseline in corresponding cohort. A positive difference indicates that AMOS cohorts show larger improvements than corresponding cohorts.